Azitra, Inc. Operating Lease Right-of-Use Assets
Azitra, Inc. (AZTR) had Operating Lease Right-of-Use Assets of $406.45 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-12
- 2026-06-30: Operating Lease, Right-of-Use Asset $406.45K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $329.35K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $404.44K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $478.67K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $406.45K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $329.35K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $404.44K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $478.67K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $552.03K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $447.90K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $527.39K 10-K · filed 2026-02-27 |
| 2024-09-30 | $606.03K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $672.80K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $750.36K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $828.96K 10-K · filed 2025-02-24 |
| 2023-09-30 | $899.62K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $976.96K 10-Q · filed 2023-08-14 |
| 2022-12-31 | $1.12M 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |